GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kun Peng International KPEA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.32

0.00%

Close of 5 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.4m

FY2020FY2025

Net income

−$1.3m

FY2020FY2025

Free cash flow

−$208,156

FY2020FY2025

Shareholders' equity

−$8.2m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Revenue$1.4m$2.1m$3.9m$7.5m$5.6m$819,130
Operating income−$1.8m−$2.0m−$2.1m−$2.0m−$1.8m−$208,873
Net income−$1.3m−$2.0m−$2.1m−$1.8m−$1.6m−$208,771
Diluted earnings per share-0.00-0.00-0.01-0.00-0.04-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assets$840,809$1.5m$1.3m$1.8m$3.2m$799,327
Cash and short-term investments———$267,131$2.1m—
Total liabilities$9.0m$8.7m$6.3m$5.4m$5.2m$1.0m
Shareholders' equity−$8.2m−$7.2m−$4.7m−$3.7m−$2.0m−$215,655
Shares outstanding400m400m400m400m40m400m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−$208,156$17,880−$427,030−$1.6m$1.9m$207,407
Capital spending—−$320,498−$606−$139,155−$19,306−$70,748
Free cash flow−$208,156−$302,618−$427,636−$1.7m$1.9m$136,659

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$31,438$22,452$174,824$364,521$107,802$609,285$356,519$480,013
Operating income−$288,233−$388,095−$296,913−$377,221−$44,865−$314,842−$698,086−$578,578
Net income−$300,111−$393,555−$265,577−$380,164−$44,865−$192,877−$645,478−$581,391
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$423,510$610,280$1.0m$840,809$694,870$804,280$1.2m$1.5m
Shareholders' equity−$9.6m−$9.1m−$8.6m−$8.2m−$8.0m−$7.9m−$7.5m−$7.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-42.4%11.9%—
Operating income-3.9%53.5%—
Net income-11.7%43.3%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-107.0%-53.0%-46.4%—
Net margin-92.0%-48.3%-42.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-61.6-25.1-24.4-26.3-0.2
Price to sales54.223.813.46.40.1

Share price return

Finished calendar years

20252024202320222021
Return-0%19%13%1299%702%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 2 Jun 2026
  • 10-for-1 split · 18 Oct 2022
  • 15-to-1 reverse split · 12 Jul 2017
  • 20-for-1 split · 28 Feb 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.